Opposite Effects of Wilms' Tumour-Suppressor Protein Isoforms on Igf2 Expression
Author Information
Author(s): A Duarte, A Caricasole, CF Graham, A Ward
Primary Institution: University of Oxford
Hypothesis
Does the p53 protein modulate the transcriptional regulation activity of the Wilms' tumour-suppressor protein (WT1)?
Conclusion
The study found that the two WT1 isoforms have opposite effects on Igf2 expression in primary embryonic cells, independent of p53 genotype.
Supporting Evidence
- WT1 [-KTS] activates Igf2 P3, whereas WT1 [+KTS] represses its activity.
- The p53 genotype does not affect WT1 transcriptional activity in these cells.
- WT1 isoforms were found to have opposite effects on gene expression from a single promoter.
Takeaway
This study shows that two versions of a protein called WT1 can either help or stop a gene from working, and this happens in baby cells that are still growing.
Methodology
The study used primary cell cultures derived from p53 wild-type and knock-out mouse embryos to investigate WT1's effects on Igf2 transcriptional regulation.
Limitations
The study's findings may not apply to all cell types or conditions, as it focused on specific primary embryonic cells.
Participant Demographics
The study involved primary mouse embryonic fibroblasts derived from p53 wild-type and knock-out embryos.
Statistical Information
Statistical Significance
p>0.05
Want to read the original?
Access the complete publication on the publisher's website